194 related articles for article (PubMed ID: 21367464)
21. 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55.
Oka S; Toshida T; Maruyama K; Nakajima K; Yamashita A; Sugiura T
J Biochem; 2009 Jan; 145(1):13-20. PubMed ID: 18845565
[TBL] [Abstract][Full Text] [Related]
22. Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells.
Harada K; Kitaguchi T; Kamiya T; Aung KH; Nakamura K; Ohta K; Tsuboi T
J Biol Chem; 2017 Jun; 292(26):10855-10864. PubMed ID: 28533434
[TBL] [Abstract][Full Text] [Related]
23. Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB2 receptor agonists: identifying novel GPR55 inhibitors.
Anavi-Goffer S; Irving AJ; Ross RA
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):303-10. PubMed ID: 27089417
[TBL] [Abstract][Full Text] [Related]
24. GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.
Bondarenko A; Waldeck-Weiermair M; Naghdi S; Poteser M; Malli R; Graier WF
Br J Pharmacol; 2010 Sep; 161(2):308-20. PubMed ID: 20735417
[TBL] [Abstract][Full Text] [Related]
25. The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells.
AlSuleimani YM; Hiley CR
Br J Pharmacol; 2015 Jun; 172(12):3043-57. PubMed ID: 25652040
[TBL] [Abstract][Full Text] [Related]
26. Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
Anavi-Goffer S; Baillie G; Irving AJ; Gertsch J; Greig IR; Pertwee RG; Ross RA
J Biol Chem; 2012 Jan; 287(1):91-104. PubMed ID: 22027819
[TBL] [Abstract][Full Text] [Related]
27. Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors.
Martínez-Aguilar LM; Ibarra-Sánchez A; Guerrero-Morán DJ; Macías-Silva M; Muñoz-Bello JO; Padilla A; Lizano M; González-Espinosa C
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047288
[TBL] [Abstract][Full Text] [Related]
28. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
Henstridge CM; Balenga NA; Ford LA; Ross RA; Waldhoer M; Irving AJ
FASEB J; 2009 Jan; 23(1):183-93. PubMed ID: 18757503
[TBL] [Abstract][Full Text] [Related]
29. Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors.
Imbernon M; Whyte L; Diaz-Arteaga A; Russell WR; Moreno NR; Vazquez MJ; Gonzalez CR; Díaz-Ruiz A; Lopez M; Malagón MM; Ross RA; Dieguez C; Nogueiras R
Mol Cell Endocrinol; 2014 Mar; 383(1-2):159-69. PubMed ID: 24378736
[TBL] [Abstract][Full Text] [Related]
30. l-α-Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK-dependent pathway.
Robertson-Gray OJ; Walsh SK; Ryberg E; Jönsson-Rylander AC; Lipina C; Wainwright CL
Pharmacol Res Perspect; 2019 Jun; 7(3):e00487. PubMed ID: 31149342
[TBL] [Abstract][Full Text] [Related]
31. GPR55-mediated effects on brain microvascular endothelial cells and the blood-brain barrier.
Leo LM; Familusi B; Hoang M; Smith R; Lindenau K; Sporici KT; Brailoiu E; Abood ME; Brailoiu GC
Neuroscience; 2019 Aug; 414():88-98. PubMed ID: 31279825
[TBL] [Abstract][Full Text] [Related]
32. Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.
Henstridge CM; Balenga NA; Kargl J; Andradas C; Brown AJ; Irving A; Sanchez C; Waldhoer M
Mol Endocrinol; 2011 Nov; 25(11):1835-48. PubMed ID: 21964594
[TBL] [Abstract][Full Text] [Related]
33. Modulation of PI3K/Akt/GSK3β signaling cascade through G protein-coupled receptor 55 (GPR55) activation: Prenatal lysophosphatidylinositol attenuates valproic acid-induced synaptic abnormalities and mitochondrial dysfunction.
Ahmed S; Abir AH; Sharmin O; Khurshid N; Akter A; Nakshy NT; Hasan MM; Yesmine S; Rahman M
Life Sci; 2023 Dec; 334():122195. PubMed ID: 37866808
[TBL] [Abstract][Full Text] [Related]
34. GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.
Kargl J; Andersen L; Hasenöhrl C; Feuersinger D; Stančić A; Fauland A; Magnes C; El-Heliebi A; Lax S; Uranitsch S; Haybaeck J; Heinemann A; Schicho R
Br J Pharmacol; 2016 Jan; 173(1):142-54. PubMed ID: 26436760
[TBL] [Abstract][Full Text] [Related]
35. A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity.
Hurst K; Badgley C; Ellsworth T; Bell S; Friend L; Prince B; Welch J; Cowan Z; Williamson R; Lyon C; Anderson B; Poole B; Christensen M; McNeil M; Call J; Edwards JG
Hippocampus; 2017 Sep; 27(9):985-998. PubMed ID: 28653801
[TBL] [Abstract][Full Text] [Related]
36. A role for GPR55 in human placental venous endothelial cells.
Kremshofer J; Siwetz M; Berghold VM; Lang I; Huppertz B; Gauster M
Histochem Cell Biol; 2015 Jul; 144(1):49-58. PubMed ID: 25869640
[TBL] [Abstract][Full Text] [Related]
37. Expression of Lysophosphatidylinositol Signaling-relevant Molecules in Colorectal Cancer.
Kitamura C; Sonoda H; Anzai H; Nagai Y; Abe S; Yokoyama Y; Ishii H; Kishikawa J; Emoto S; Murono K; Sasaki K; Kawai K; Nozawa H; Ishihara S
Anticancer Res; 2021 May; 41(5):2349-2355. PubMed ID: 33952459
[TBL] [Abstract][Full Text] [Related]
38. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo.
Whyte LS; Ryberg E; Sims NA; Ridge SA; Mackie K; Greasley PJ; Ross RA; Rogers MJ
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16511-6. PubMed ID: 19805329
[TBL] [Abstract][Full Text] [Related]
39. Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor.
Lingerfelt MA; Zhao P; Sharir HP; Hurst DP; Reggio PH; Abood ME
Biochemistry; 2017 Jan; 56(3):473-486. PubMed ID: 28005346
[TBL] [Abstract][Full Text] [Related]
40. Interactions between lysophosphatidylinositol receptor GPR55 and sphingosine-1-phosphate receptor S1P
Hong H; Yoon B; Ghil S
Biochem Biophys Res Commun; 2021 Sep; 570():53-59. PubMed ID: 34271437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
